INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
PHARMA PRODUCT DEVELOPMENT CREATES A SPAGHETTI

PHARMA PRODUCT DEVELOPMENT CREATES A SPAGHETTI

Where was the supply chain thinking?

Hedley Rees's avatar
Hedley Rees
Feb 10, 2022
∙ Paid
5

Share this post

INSIDE PHARMA
INSIDE PHARMA
PHARMA PRODUCT DEVELOPMENT CREATES A SPAGHETTI
Share

INTRODUCTION TO THE SPAGHETTI

The diagram below shows the spaghetti supply chains that emerge from the pharmaceutical development process:

The various company business models on the top right-hand side of the diagram create the supply chains during pre-clinical and clinical development. They do not own any of the companies physically building and running the supply chains, as it has all been outsourced—development, manufacture and distribution.

WHAT ARE THE CONSEQUENCES?

With my consulting head on, there seems to be little awareness among actors in the development process of the seminal impact decisions taken there can have on the quality, cost, and service performance of the future commercial supply chain. The focus is exclusively on producing the data required to gain regulatory approval.

The consequences can be debilitating for the future supply chain. Here are some of the problems that may have been locked-in during development:

  • Scarce/bespoke materials specified

  • Sole sourcing from far o…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share